Assessment of Intestinal Free Fatty Acid Binding Protein 4 in Alopecia Areata Patients

October 2024 in “ Skin Appendage Disorders ”

A.E. Soliman, Olfat Shaker, Samar El‐Tahlawi, Ghada Abdaltwab Mahgoub, Sara M Yaseen

alopecia areata intestinal free fatty acid binding protein 4 FABP4 biomarker AA

TLDR Higher FABP4 levels may indicate more severe alopecia areata.

The study investigates the role of intestinal free fatty acid binding protein 4 (FABP4) in patients with alopecia areata (AA). It suggests that elevated levels of FABP4 in the serum may correlate with the severity of the disease, indicating that FABP4 could be significant in diagnosing AA. This finding highlights the potential of FABP4 as a biomarker for assessing disease severity in AA patients.

View this study on karger.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Comparing the Burden of Illness in Patients with Alopecia Areata vs Atopic Dermatitis in the US Population from a Payer Perspective

10 citations , March 2023 in “Journal of Managed Care & Specialty Pharmacy”

Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.

research Expression of Long Noncoding RNA HOTAIR and MicroRNA-205 and Their Relation to Transforming Growth Factor Beta 1 in Patients with Alopecia Areata

4 citations , January 2023 in “Skin Appendage Disorders”

Changes in certain RNA and protein levels may contribute to alopecia areata and could be treatment targets.

research Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic Review and Meta-Analysis

6 citations , August 2020 in “Dermatology and Therapy”

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.